Different Approaches for the Management of Post-dural Puncture Headache

Bahaa Mohammed Refaie

Status: Completed

Conditions: Post-Dural Puncture Headache

Treatments: Drug: paracetamol; Procedure: sphenopalatine ganglion block

Study type: Interventional

Funder types: Other

Identifiers

NCT05253014

2223

Details and patient eligibility

About

Detecting the efficacy and safety of trans-nasal sphenopalatine ganglion block using either lidocaine 2% or bupivacaine 0.5 % as a treatment line for post-dural puncture headache

Enrollment: 120 patients

Sex: Female

Ages: 20 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• The ASA physical condition І-П
• the patient underwent CS under spinal anesthesia
• The headache developed within 5 days after the dural puncture
• There is no different explanation for the headache

Exclusion criteria

• coagulopathy
• history of nasal bleeding
• nasal polyp
• septal deviation
• local anesthetics reaction

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

120 participants in 3 patient groups

lidocaine group

Active Comparator group

Treatment:

Procedure: sphenopalatine ganglion block

bupivacaine group

Active Comparator group

Treatment:

Procedure: sphenopalatine ganglion block

conservative group

Active Comparator group

Treatment:

Drug: paracetamol